M
美加康
HEALTH8/25/2026

Long-Term Management After Liver Transplantation: Key Guide to Medication and Follow-Up

Liver transplantation is an effective treatment for end-stage liver disease, but long-term postoperative management directly affects graft survival and quality of life. This article provides a detailed analysis of immunosuppressant medication essentials, regular follow-up items, infection prevention, and lifestyle adjustments to help patients establish a scientific management plan, reduce complication risks, and improve long-term survival quality.

Introduction

After liver transplantation, patients often focus on the surgery itself but overlook the importance of long-term postoperative management. In reality, a successful transplant is only the first step; lifelong medication and regular follow-up are the cornerstones of ensuring stable graft function and extending survival. According to statistics, the 1-year survival rate after liver transplantation exceeds 90%, and the 5-year survival rate can reach over 75%, but this depends on strict postoperative management. This article provides a systematic management guide for international patients from four dimensions: medication, follow-up, infection prevention, and lifestyle adjustments.

Scientific Use of Immunosuppressants

Immunosuppressants are the core drugs for preventing rejection. Common regimens include tacrolimus or cyclosporine combined with mycophenolate mofetil, with some patients adding corticosteroids. Key medication points are as follows:

  • Fixed timing and dosage: Take medication at the same time daily, with a 12-hour interval, to maintain stable blood drug concentrations. It is recommended to set alarms or use pill organizers to avoid missed doses.
  • Blood drug concentration monitoring: Test every 1-2 weeks in the early postoperative period, which can be extended to every 3-6 months once stable. Target concentrations vary by individual and postoperative time; for example, trough levels of tacrolimus are typically maintained at 5-10 ng/mL within the first 3 months after surgery, and can be appropriately reduced thereafter.
  • Drug interactions: Avoid self-administering over-the-counter medications, especially antifungals, macrolide antibiotics, and grapefruit juice, as they can significantly affect immunosuppressant metabolism. If other medications are needed, always consult the transplant team.
  • Side effect management: Long-term use can lead to hypertension, diabetes, kidney injury, etc., requiring regular monitoring of blood pressure, blood glucose, and renal function, along with dietary control. If symptoms such as tremors, headaches, or diarrhea occur, promptly report to the doctor for dose adjustment.
  • Key Items in Follow-Up Monitoring

    Regular follow-up can promptly detect rejection, infection, or drug toxicity. Recommended follow-up frequency: weekly within the first 3 months after surgery, every two weeks from 3-6 months, monthly from 6 months to 1 year, and every 3-6 months after 1 year, but this should be adjusted based on the condition. Each follow-up includes:

  • Blood tests: Liver function (ALT, AST, bilirubin), renal function (creatinine, blood urea nitrogen), complete blood count, and immunosuppressant blood drug concentrations.
  • Virological tests: Patients with hepatitis B or C need monitoring of viral load and surface antibody titers to prevent recurrence. Opportunistic infections such as cytomegalovirus and Epstein-Barr virus should also be regularly screened.
  • Imaging studies: Liver Doppler ultrasound every 6-12 months to assess vascular patency and detect tumor recurrence. If the primary disease was liver cancer, more frequent imaging follow-up is needed.
  • Tumor markers: Monitor alpha-fetoprotein (AFP) levels in liver cancer patients.
  • Quality of life assessment: Use scales such as SF-36 to focus on psychological status and social function, providing psychological support when necessary.
  • Infection Prevention and Vaccination

    Under immunosuppression, the risk of infection significantly increases, requiring proactive preventive measures:

  • Personal hygiene: Wash hands frequently, avoid contact with people with colds or shingles, avoid crowded places, and wear masks when going out.
  • Environmental hygiene: Keep the home well-ventilated, avoid contact with pet feces and soil to prevent toxoplasmosis and fungal infections.
  • Vaccination: After 6 months post-surgery, under medical guidance, receive inactivated vaccines such as influenza vaccine, pneumococcal vaccine, and COVID-19 vaccine (non-live viral vector). Live vaccines (e.g., measles, varicella, yellow fever vaccines) are absolutely contraindicated.
  • Antimicrobial prophylaxis: In the early postoperative period (usually 6-12 months), take trimethoprim-sulfamethoxazole to prevent Pneumocystis jirovecii pneumonia, and regularly assess whether to continue.
  • Watch for symptoms: Fever (temperature >38°C), chills, difficulty breathing, diarrhea, etc. Any signs of infection should prompt immediate medical attention, and the transplant history should be disclosed.
  • Lifestyle Adjustments and Self-Management

    A healthy lifestyle helps reduce metabolic complications and protect graft function.

  • Diet: Maintain balanced nutrition, control salt intake (less than 5g daily), limit fats and sugars, and increase high-quality protein (fish, chicken, soy products). Avoid raw seafood and undercooked meat to prevent infections.
  • Exercise: Moderate-intensity exercise can begin 3 months after surgery, such as brisk walking, swimming, or yoga, for at least 150 minutes per week. Avoid intense contact sports to prevent abdominal trauma.
  • Weight management: Maintain a BMI between 18.5 and 24.9. Overweight individuals need to control caloric intake but should avoid crash dieting; consult a nutritionist if needed.
  • Smoking cessation and alcohol restriction: Both tobacco and alcohol increase the burden on the liver and must be completely eliminated.
  • Mental health: Long-term medication and follow-up can easily lead to anxiety and depression. It is recommended to participate in transplant patient support groups or seek psychological counseling. Family support is equally important.
  • Recommendations for International Patients

    For international patients planning liver transplantation in China, MeiJiaKang provides full support. Before surgery, please bring complete medical records, including diagnosis of the primary disease, imaging, and liver and kidney function reports, for the transplant team to evaluate. After surgery, strictly follow medical advice, take medications on time, and attend follow-ups; never adjust medications on your own. If you need to return to your home country, it is recommended to bring sufficient medication (with translated prescriptions) and establish contact with a local transplant center, regularly sending follow-up results to the original transplant team. MeiJiaKang can assist in arranging regular check-ups, medication delivery, and telemedicine consultations to ensure continuity of care.

    For details on post-liver transplant management or to schedule follow-up services, feel free to contact us or use the cost estimator for reference. Our team will provide personalized guidance to help you smoothly navigate the recovery period.

    Disclaimer: This article is for informational purposes only. Individual outcomes vary. Always consult with qualified medical professionals before making treatment decisions. Contact MedBridge Shanghai for personalized consultation.

    Ready to Start Your Medical Journey?

    Free consultation with our medical experts. Get a personalized treatment plan within 48 hours.

    Free Consultation